Carga económica y uso de antibióticos en enfermos con infecciones abdominales adquiridas en la comunidad

Abstract

Currently, intra-abdominal sepsis continues to present changes and modifications as well as medical management and in spite of continuous advances in therapy with high mortality rates ranging between 30 and 60%. Important to stress that abdominal sepsis represents multiple alterations of various organs and systems, translocation bacterial metabolic failure at q is vital that the therapeutic elements that strengthen organizational response such as the proper and timely use of antibiotics to implement, nutritional support, parenteral and enteral strict body fluid and the most important microbial poly intensive local treatment including the most common agents found Escherichia coli, Enterococcus faescium, Enterococcus fecalis, contributing to the severity and prognosis of the patient, the most common causes were: pancreatitis, and cholangitis complicated appendicitis. As the use of antibiotics to use empirically and according to microbiological findings reported taking into account the sensitivity and resistance to each of them in our hospital was found the start of triple therapy with antibiotics based scheme amikacin, cefotaxime and metronidazole or using dual schema based on cefotaxime and metronidazole, since in both cases had tested by antibiogram sensitivity of 64% and where antibiotic resistance were found and reported in those patients in whom monotherapy was used or they were referred to quinolones. It is now important to understand these results, to significantly reduce the high costs of inpatient, day hospital stay, and secondary complications during their stay, and to improve the prognosis with emphasis on the use efficient antibiotics and therapeutic measures implemented in a timely manner.